ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 094,58
0,03%
Dow Jones
39 671,04
-0,51%
DAX
18 699,64
0,09%
Brent Oil
81,945
0,51%
Bitcoin
69 692,10
0,85%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. AMEX
  6. China Pharma Holdings Inc (CPHI)

  7. China Pharma Holdings Inc (CPHI) Actualités

CPHI

China Pharma (CPHI)

China Pharma Holdings Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:CPHI
DateHeureSourceTitreSymboleSociété
15/05/202422h06Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:CPHIChina Pharma Holdings Inc
08/05/202422h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:CPHIChina Pharma Holdings Inc
23/02/202422h05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
15/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:CPHIChina Pharma Holdings Inc
06/02/202422h16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]AMEX:CPHIChina Pharma Holdings Inc
26/01/202423h04Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:CPHIChina Pharma Holdings Inc
26/01/202423h04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
12/01/202422h05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933AMEX:CPHIChina Pharma Holdings Inc
12/01/202420h42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:CPHIChina Pharma Holdings Inc
29/11/202314h00PR Newswire (US)China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceAMEX:CPHIChina Pharma Holdings Inc
07/11/202322h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:CPHIChina Pharma Holdings Inc
27/10/202322h06Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:CPHIChina Pharma Holdings Inc
19/10/202322h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:CPHIChina Pharma Holdings Inc
09/08/202314h30PR Newswire (US)China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsAMEX:CPHIChina Pharma Holdings Inc
12/05/202322h07Edgar (US Regulatory)Quarterly Report (10-q)AMEX:CPHIChina Pharma Holdings Inc
30/03/202322h56Edgar (US Regulatory)Annual Report (10-k)AMEX:CPHIChina Pharma Holdings Inc
29/03/202322h06Edgar (US Regulatory)Current Report Filing (8-k)AMEX:CPHIChina Pharma Holdings Inc
09/03/202322h07Edgar (US Regulatory)Statement of Ownership (sc 13g)AMEX:CPHIChina Pharma Holdings Inc
09/03/202322h06Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)AMEX:CPHIChina Pharma Holdings Inc
24/02/202322h05PR Newswire (US)China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock SplitAMEX:CPHIChina Pharma Holdings Inc
28/12/202214h00PR Newswire (US)China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective MaskAMEX:CPHIChina Pharma Holdings Inc
15/12/202214h00PR Newswire (US)China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19AMEX:CPHIChina Pharma Holdings Inc
05/12/202221h02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)AMEX:CPHIChina Pharma Holdings Inc
05/12/202214h00PR Newswire (US)China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device ProjectAMEX:CPHIChina Pharma Holdings Inc
02/12/202222h10PR Newswire (US)China Pharma Announces Receipt of Noncompliance Notice from NYSE AmericanAMEX:CPHIChina Pharma Holdings Inc
14/11/202223h32Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)AMEX:CPHIChina Pharma Holdings Inc
04/11/202221h34Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)AMEX:CPHIChina Pharma Holdings Inc
24/10/202222h18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)AMEX:CPHIChina Pharma Holdings Inc
02/10/202204h05PR Newswire (US)China Pharma Announces Receipt of Notification of NYSE American Listing DeficiencyAMEX:CPHIChina Pharma Holdings Inc
18/07/202214h00PR Newswire (US)China Pharma Announced the Submission of a Plan of Compliance to NYSE AmericanAMEX:CPHIChina Pharma Holdings Inc
 Showing the most relevant articles for your search:AMEX:CPHI

Dernières Valeurs Consultées

EU
VIV
Vivendi
NYSE
MRK
Merck
EU
SGO
Cie de SaintGobain
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
MSFT
Microsoft
NYSE
MCD
McDonalds
EU
CAP
Capgemini
EU
ML
Michelin
SPI
SP500
S&P 500
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
EU
BEL20
Bel 20
EU
ORA
Orange
EU
AI
Air Liquide
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés